Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.

Sabolinski ML, Capotorto JV.

Open source

DOI
10.2217/cer-2019-0001
Published
2019-08-13
Container
J Comp Eff Res
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2217/cer-2019-0001,
  title = {Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.},
  author = {Sabolinski ML and  Capotorto JV.},
  year = {2019},
  journal = {J Comp Eff Res},
  doi = {10.2217/cer-2019-0001},
  url = {https://doi.org/10.2217/cer-2019-0001}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
AU  - Sabolinski ML
AU  -  Capotorto JV.
PY  - 2019
JO  - J Comp Eff Res
DO  - 10.2217/cer-2019-0001
UR  - https://doi.org/10.2217/cer-2019-0001
ER  - 

APA

ML, S., & JV., C. (2019). Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.. J Comp Eff Res. https://doi.org/10.2217/cer-2019-0001

Source records